Letter: the BSG COVID-19 interim coeliac disease guidance no-biopsy approach is safe in adults

Aliment Pharmacol Ther. 2021 Oct;54(8):1090-1092. doi: 10.1111/apt.16553.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adult
  • Autoantibodies
  • Biopsy
  • COVID-19*
  • Celiac Disease*
  • Humans
  • SARS-CoV-2

Substances

  • Autoantibodies